Home Intersect ENT

Intersect ENT

acquired
Post-IPO Round
Developer of ENT Medical Devices

Basic Information

Intersect ENT is a developer of otorhinolaryngological medical devices, primarily providing advanced treatment solutions for ENT specialists to ensure better patient care. The company has developed sinus drug delivery technology, including the PROPEL dissolvable implant for patients with chronic sinusitis undergoing sinus surgery, which prevents postoperative blockage of the ethmoid sinus and allows patients to recover quickly after surgery.
Intersect ENT, Inc.
California,United States of America
101~500 people
January 01, 2003
info@intersectENT.com